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Abstract: Posterolateral spinal fusion (PLF) is a common proce-
dure in orthopedic surgery that is performed to fuse adjacent
vertebrae to reduce symptoms related to spinal conditions. In
the current study, a novel synthetic calcium phosphate with
submicron surface topography was evaluated as an autograft
extender in a validated rabbit model of PLF. Fifty-nine skele-
tally mature New Zealand white rabbits were divided into three
groups and underwent single-level intertransverse process PLF
at L4-5 using (1) autologous bone graft (ABG) alone or in a
1:1 combination with (2) calcium phosphate granules
(ABG/BCPgranules), or (3) granules embedded in a fast-resorbing
polymeric carrier (ABG/BCPputty). After 6, 9, and 12 weeks,
animals were sacrificed and spinal fusion was assessed by
manual palpation, Radiographs, micro-CT, mechanical testing
(12 weeks only), histology, and histomorphometry. Based on
all endpoints, all groups showed a gradual progression in
bone formation and maturation during time, leading to solid
fusion masses between the transverse processes after
12 weeks. Fusion assessments by manual palpation, radiogra-
phy and histology were consistent and demonstrated equiva-
lent fusion rates between groups, with high bilateral fusion
rates after 12 weeks. Mechanical tests after 12 weeks indicated
substantially lower range of motion for all groups, compared
to non-operated controls. By histology and histomorphometry,
the gradual formation and maturation of bone in the fusion
mass was confirmed for each graft type. With these results, we
describe the equivalent performance between autograft and a
novel calcium phosphate material as an autograft extender in
a rabbit model of PLF using an extensive range of evaluation
techniques. © 2019 Wiley Periodicals, Inc. J Biomed Mater Res B Part
B: 00B: 000–000, 2019.
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INTRODUCTION
Spinal fusion is a frequent procedure in orthopedic sur-
gery, which is performed to fuse vertebrae of the spine to
improve symptoms resulting from spinal trauma, degener-
ative conditions, scoliosis or tumor resections. The pos-
terolateral spinal fusion (PLF) technique is commonly
performed in the lumbar spine and involves bilateral
implantation of bone graft between the transverse pro-
cesses of adjacent vertebrae. Although autologous bone is
the gold standard graft for spinal fusion procedures, pseu-
doarthrosis and non-unions are still frequently reported
complications of this treatment.1–6 Moreover, the required
harvesting of large autograft volumes, usually obtained
from the iliac crest, leads to morbidity7,8 and persistent
post-surgical pain in up to 60% of patients.2
In order to improve the fusion rate of PLF procedures and to
reduce the amount of bone autograft to be harvested, there has
been an increasing interest in calcium phosphate materials that
can support spinal bone formation as autograft extenders.9,10
Synthetic calcium phosphates are generally osteoconductive and
highly biocompatible, making them suitable biomaterials for use
in bone surgery. As mere osteoconductive materials, their regen-
erative potential is limited and the presence of an osteogenic
or osteoinductive adjunct is favored for bone growth to occur.
However, a subset of calcium phosphates with optimized physico-
chemical properties was demonstrated to have exceptional
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bone-inducing properties on its own,11–13 showing enhanced
regenerative performance in pre-clinical studies.11–14 Spe-
cifically, the presence of a submicron surface topography
was related to the enhanced bone-inducing potential of
these calcium phosphates.11,13–15 Interestingly, studies have
demonstrated that surface properties of biomaterials can
influence the phenotype of macrophages,16–18 immune cells
that govern the foreign body response and wound healing
response.19 An increase in anti-inflammatory M2 macrophages
following an initial inflammatory phase has been shown to be
beneficial for bone formation20 and vascularization21 and
recently, macrophages cultured on calcium phosphates with sub-
micron surface topography were demonstrated to adopt the M2
phenotype.22 This suggests a connection between surface topog-
raphy, macrophage phenotype and the enhanced vasculariza-
tion22 and bone formation observed with submicron surface
structured calcium phosphates in vivo.
The current study describes the evaluation of a novel
synthetic calcium phosphate with surface topography con-
sisting of submicron polygon crystals in a validated rabbit
model of PLF, which is well-described for studies of auto-
graft extender efficacy.23–26 Either in granular form or as
granules embedded within a fast-resorbing polymeric carrier
material designed to improve handling properties, the cal-
cium phosphate was combined with iliac crest-derived bone
graft in a 1:1 ratio, after which the graft composites were
implanted. Study outcomes included fusion rate by manual
palpation, radiography, micro-computed tomography and
histology at 6, 9, and 12 weeks post-surgery. Furthermore,
biomechanical analysis of the spines and histomorphometry
of bone and material in the fusion mass were performed.
MATERIALS AND METHODS
Graft materials
Calcium phosphate granules. Commercially available
biphasic calcium phosphate (BCP) bone graft (MagnetOs;
Kuros Biosciences) was provided in granule and putty for-
mulations. Both formulations contained 1–2 mm granules of
bioactive bone graft comprising 65–75% Tri-Calcium Phos-
phate (TCP – Ca3(PO4)2) and 25–35% Hydroxyapatite (HA –
Ca10(PO4)6(OH)2). The granules were manufactured from
porous BCP blocks produced by use of calcium orthophos-
phate powder, foaming agent and porogen. Blocks were
dried, sintered and crushed to obtain granules (1–2 mm)
which were subsequently exposed to a hydrothermal treat-
ment to create submicron surface topography [Fig. 1(A)].
Submicron size of surface crystals was confirmed by scan-
ning electron microscopy (SEM, JEOL JSM-5600, JEOL Ltd,
Tokyo, Japan), revealing an average crystal diameter of
0.58  0.21 μm.
Polymeric carrier. For the putty formulation, a tri-block
copolymer was synthesized from polyethylene glycol (PEG,
80–90 mol %) and L-lactide monomer (10–20 mol %), with
a molecular weight of 2–3 kDa. The resulting polymer is
water-soluble and dissolves near body temperature, leading
to rapid dispersion after implantation (<48 h). The BCP
granules and binder were combined to obtain a moldable
putty. The materials were sterilized by gamma irradiation
(25 kGy).
Autologous bone graft and graft composites. The iliac
crests were exposed from the caudal aspect of the midline
incision used to approach the spine. Corticocancellous bone
was harvested from both iliac crests using a Miltex Rongeur.
Volume and weight of the autologous bone graft (ABG) parti-
cles (< 5 mm in size) was measured in a 3 mL syringe (tip
removed) and a laboratory balance [Fig. 1(B)]. A volume of
1 cc (~0.8 g) of autograft particles was combined with 1 cc
of BCP granules (ABG/BCPgranules) [Fig. 1(C,D)]. Likewise,
1 cc of autograft particles was combined with 1 cc of putty
(ABG/BCPputty) [Fig. 1(E,F)]. Volumes of 2 cc of ABG,
ABG/BCPgranules and ABG/BCPputty were determined for
implantation on each side of the spine (4 cc total per level).
A volume of 2 cc of autograft per side is known to achieve
spinal fusion in this rabbit model, as has been reported in lit-
erature.27 Furthermore, a volume of 1 cc of autograft has
been reported to be unable to achieve fusion in this model.28
Animal model and surgical procedure
After approval of the Institutional Animal Care and Ethics Com-
mittee (ACEC approval 14/110A, UNSW, Australia), 54 adult
New Zealand white rabbits underwent single-level bilateral
posterolateral intertransverse process spine arthrodesis at L4–
L5. Skeletal maturity was confirmed prior to being enrolled in
the study by radiographic confirmation of the closure of the
growth plates of the proximal tibia. The animals were sedated
with a mixture of midazolam (5 mg/mL at 0.3–0.5 mg/kg) and
buprenorphine (0.326 mg/mL at 0.03–0.05 mg/kg) intramus-
cularly. Anesthesia was applied and maintained via isoflurane
inhalation (2–3%) with oxygen. Once the rabbits were
anesthetized, the skin was incised from the L3–L5 levels.
The intermuscular plane between the multifidus and longis-
simus muscles was separated in a blunt fashion to expose
the transverse processes as well as the intertransverse
membrane. A pneumatic burr (Midax Rex) was used with
an M8 matchstick burr to prepare the host bone between
the levels by decortication. The transverse processes were
carefully decorticated for a distance of 10 mm from the ver-
tebral body and pars to a level where bleeding bone beds
were visually present to the surgeon.
The animals were divided into three groups: (1) ABG,
(2) ABG/BCPgranules, and (3) ABG/BCPputty. For each group, a
total volume of 2 cc graft material per side (4 cc per level)
was implanted between the L4–L5 transverse processes in
the paraspinal bed. After implant placement, the muscle
layers were allowed to return to their native position and
the fascial incisions were closed with 3–0 absorbable sutures
and the skin approximated using 3–0 sutures. Post-operative
pain was managed using a non-steroid anti-inflammatory
drug (Carprofen, 50 mg/mL, dose 2–4 mg/kg) for the first
2–3 days. The animals were housed in individual cages, fed
ad libitum and monitored daily for the first 7 days following
surgery and weekly thereafter. Animals were euthanized
at 6 (n = 5), 9 (n = 5), and 12 (n = 8) weeks after surgery,
and spinal fusion was determined by manual palpation,
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radiography (Faxitron and micro-CT), mechanical testing
(range of motion testing at 12 weeks only) and histology
(decalcified and undecalcified). For the mechanical testing,
five non-operated animals were included as baseline con-
trols. For determining BCP material percentage in the
implantation bed after surgery at time-point zero, 12 animals
were used.
Radiographic analysis
Faxitron radiography. After harvesting the spines were
immediately radiographed in the posteroanterior plane using
a Faxitron (Faxitron Bioptics LLC, Arizona, USA) and digital
plates (Agfa CR MD 4.0 cassette, Agfa, Germany). An Agfa
Digital Developer and workstation was used to process the
digital images (Agfa CR 75.0 Digitizer Musica, Agfa, Ger-
many). The DICOM data was converted to bitmap images
using DICOM Works (ezDICOM medical viewer, 2002).
Radiographic status of the PLF was evaluated on the post-
sacrifice anteroposterior faxitron radiographs utilizing the
Lenke four-point grading scale.29 A grade A was given to a
fusion where it was deemed definitely solid with bilateral
robust bridging bone. A grade B was given to a fusion where
it was deemed probably solid with unilateral robust bridging
bone and contralateral thin fusion mass. A grade C was given
to a fusion where it was deemed probably not solid with a
thin unilateral fusion mass and a probable pseudarthrosis on
the contralateral side. A grade D was given to a fusion where
it was deemed definitely not solid with thin fusion masses
bilaterally with obvious pseudarthrosis or bone graft disso-
lution bilaterally. The occurrence of each grade (A–D) was
determined based on faxitron image review by two indepen-
dent observers blinded to treatment group and time-points.
Micro-computed tomography. Micro computed tomography
(μCT) scanning was performed on all animals following radi-
ography using an Inveon in-vivo micro computed tomogra-
phy scanner (Siemens Medical, PA, USA) to obtain high-
resolution radiographic images of the spinal fusions in three
planes. Spines were scanned and the raw images recon-
structed to DICOM data using Siemens software at a resolu-
tion of 53 microns. Images were examined in the axial,
sagittal and coronal planes to assess the overall quality of
FIGURE 1. Graft materials used in PLF model, including (A) surface of submicron epitaxial polygon crystals observed on BCP granules by SEM,
(B) iliac crest-derived autologous bone graft particles (ABG), (C, D) calcium phosphate granules and autograft particles combined in a 1:1 ratio
(ABG/BCPgranules), and (E, F) granules embedded in polymeric carrier combined with autograft particles in a 1:1 ratio (ABG/BCPputty).
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the fusion mass from transverse process to transverse pro-
cess in a similar manner to the other radiographic data.
Anterior and posterior 3D models were also created for each
animal. The μCT reconstructions were assessed for fusion
between the treated levels by two trained and experienced
observers who reviewed the coronal and sagittal planes in a
blinded manner to treatment groups and time-points. The
μCTs were graded using the four-point Lenke radiographic
grading score29 as described above.
Manual palpation
Immediately after harvest, the stability of the lumbar spine
of all animals was assessed by manual palpation according
to Boden et al.23 Two trained and experienced observers
assessed the treated motion segment in a blinded manner in
lateral bending and flexion/extension and compared it to the
proximal and distal motion segments. The motion segments
at L4–L5 were graded as either fused (rigid, no detectable
movement at the disc space) or not fused (not rigid, move-
ment detected at the disc space).
Biomechanical testing
Non-destructive range of motion testing was performed at
12 weeks to provide a kinematic, multidirectional flexibility
analysis of the rabbit lumbar spine. Spines were tested with
pure moments using a Denso robot (simVITRO; Cleveland
Clinic BioRobotics Lab, Cleveland, OH) to avoid off axis
moments and spurious loading. After fixing the spines in cus-
tom molds with resin, moments as per Grauer et al.30
(270 Nċmm) were applied in axial rotation (AR), flexion-
extension (FE), and lateral bending (LB). Moments of
270 Nmm were applied at a rate of 33.3 Nmm per second to
a maximum of 300 Nmm, and was held for 15 s. A total of 4.5
load – unload cycles were run in each profile. The last three
cycles were analyzed and a mean value at 270 Nmm was
taken for each cycle and averaged. Range of motion testing
was performed using robotic testing and intact, non-operated
skeletally mature female rabbit spines (n = 5) that had no pre-
vious surgery were evaluated to provide a comparison.
Histology and histomorphometric analysis
All spines were immediately fixed for a minimum of 96 h in
10% formalin in 0.145 M phosphate buffered saline under
gentle rotation, following mechanical testing. The spines were
cut in the sagittal plane through the middle of vertebral body
using a hacksaw and one side was randomly processed for
decalcified paraffin histology and the other side processed for
undecalcified polymethyl methacrylate (PMMA) histology. Dec-
alcified histology was used to determine general tissue
response and the presence of histological fusion. Undecalcified
histology was used for the quantitative determination of bone
formation and graft resorption.
Decalcified histology. The portion of the spines allocated for
paraffin histology was decalcified in 10% formic acid in
phosphate buffered formalin at room temperature for
3–4 days prior to further processing. The decalcified spines
were then sectioned to provide detailed histology from the
entire fusion mass from medial to lateral, which resulted in
to at least four blocks from the treated spinal unit from
transverse processes in the posterolateral fusion space. The
blocks (~3 mm in thickness) were then embedded in paraf-
fin and sectioned (5 microns) using a Leica Microtome
(Leica Microsystems Pty Ltd, North Ryde, Australia). A mini-
mum of three sections were cut from each paraffin block
and stained with hematoxylin and eosin (H&E). Stained sec-
tions were examined in a blinded fashion (to treatment
groups and time-points) using an Olympus light microscope
(Olympus, Japan) with a DP72 high-resolution video camera
(Olympus, Japan). Examination included qualitative assess-
ment of general tissue response, the presence of inflamma-
tory cells or tissue necrosis, evidence of graft resorption,
new bone formation, marrow space development and bony
fusion between both transverse processes. In addition, Rallis’
Tetrachrome31 staining was performed on decalcified sec-
tions in order to visualize bone maturation.
Undecalcified histology. The portion of the spines allocated
for histomorphometric analysis was dehydrated through a
series of ethanol and embedded in PMMA. A Leica SP1600
saw-microtome (Leica Microsystems Pty Ltd., North Ryde,
Australia) was used to cut ~15 micron thick sections in the
sagittal plane that were stained with methylene blue (Sigma,
1% in 0.1 M borax buffer, pH 8.5) and basic fuchsin (Sigma,
0.3% in water).13 Three sections were cut from each PMMA
block, with a ~2 mm interval to evaluate the entire fusion
mass from medial to lateral. Low magnification images were
used for histomorphometric analysis.
Histomorphometry. Three low magnification images (1.25×,
1 mm scale bar) taken from the transverse process, the mid-
dle of the fusion and the other transverse process were used
for quantitative analysis. The region-of-interest (ROI) was
determined by an observer blinded to treatment groups or
time-points, using a polygon technique and graft material or
bone tissue (mineralized bone and bone marrow elements)
was identified by pixel color and morphology assessment.
Their respective area was determined as a percentage of the
ROI, and a mean value was obtained for each animal based
on the three PMMA sections.
Statistical analysis
SPSS for Windows (SPSS, Chicago, IL) was used for statistical
analysis. Fusion grading data were analyzed using a
Kruskal–Wallis analysis of variance. Biomechanical testing
data was analyzed using a one-way analysis of variance fol-
lowed by a Games Howell post-hoc test when appropriate.
Analysis of variance followed by a Games Howell post hoc
test was performed on the histomorphometry data. Statisti-
cal significance was set at p < 0.05.
RESULTS
Surgery
Surgery was uneventful and no post-operative complications
were observed. All animals ambulated normally throughout
the study and were euthanized at their allocated time-points.
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Radiographic analysis
Post-operative radiographs demonstrated proper implantation
position for all animals, which was maintained for all graft types
for the entire study duration. No migration of BCP granules from
the implantation site was observed for ABG/BCPgranules and
ABG/BCPputty on radiographs and by micro-CT. For all groups, a
progression in healing was observed during time. Radiographs
showed the progression of a fusion mass with autograft and BCP
particles with well-defined borders at 6 weeks toward a more
homogeneous mass by 12 weeks for all groups [Fig. 2(A–C)]. By
micro-CT, evidence of bone formation on the decorticated host
bone transverse processes was observed at 6 weeks with all
groups. During time, the autograft and BCP particles coalesced by
new bone formation and bone remodeling, leading to solid fusion
mass by 12 weeks for all groups [Fig. 2(D–F)]. Fusion grading
was performed according to the Lenke scale on radiographs [Fig. 3
(B)] and micro-CT [Fig. 3(C)]. Grading distributions were similar
between all groups at each time-point, with no statistically signifi-
cant differences. A high occurrence of solid bilateral fusion (grade
A) was determined after 12 weeks, corresponding to fusion rates
of 75%, 87.5%, and 75% by radiography and 87.5%, 100%, and
87.5% by micro-CT for ABG, ABG/BCPgranules and ABG/BCPputty,
respectively.
Manual palpation
Fusion assessment by manual palpation revealed a similar
fusion distribution across groups at each time-point [Fig. 3
(A)]. At 6 weeks, bilateral fusion was determined in only one
of five spines for both ABG/BCPgranules and ABG/BCPputty,
while no fusion was observed for ABG. During time, fusion
had increased to three of five at 9 weeks and six of eight at
12 weeks for all groups, corresponding to a fusion rate of
75% for the latest time-point. No statistically significant dif-
ferences were determined between treatments.
Biomechanical testing
Results of range-of-motion (ROM) analysis measured after
12 weeks are presented in Table I. Non-operated control
FIGURE 2. Radiography. (A–C) Examples of faxitron radiographs taken after 12 weeks for (A) ABG, (B), ABG/BCPgranules, and (C) ABG/BCPputty. (D–F)
Examples of 3D micro-CT reconstructions taken after 12 weeks for (D) ABG, (E), ABG/BCPgranules, and (F) ABG/BCPputty. Faxitron radiographs and
micro-CT reconstructions show the presence of graft material bridging the intertransverse process space of the treated levels in all groups.
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spines had a ROM of 18.8 1.9 in LB and 20.7 2.9 FE, indicat-
ing baseline ROM. With a difference of 50% or more as com-
pared to the controls, the ROM of treated spines in LB and FE
after 12 weeks was significantly lower for all groups (p < 0.001).
Between treatments, ROM of ABG and ABG/BCPgranules were
equivalent in both measuring movements, with no significant
differences. Also, ROM between ABG/BCPgranules and ABG/
BCPputty was similar in LB. For ABG/BCPputty, ROM was slightly
higher than other treatments in LB (ABG p < 0.001) and FE (ABG
p < 0.05, ABG/BCPgranules p < 0.05). There was no significant dif-
ference (p > 0.05) in axial rotation between the negative control
(un-operated spine) and the positive control (autograft). Fur-
thermore, there were no differences between the BCP treat-
ments and either control.
Histology and histological grading
Histological observations are presented in examples of low-
magnification overviews (Fig. 4) and high magnification
micrographs (Figs. 5 and 6). On the histological overviews,
fusion was determined in case of a bridge of bone tissue in
the fusion mass connecting the adjacent transverse pro-
cesses. By this method, fusion rates of 0–20% at 6 weeks,
FIGURE 3. Diagrams presenting the fusion rate as determined by (A) manual palpation, (B) X-ray, (C) micro-CT, and (D) histology. For A and B, only
the percentage of treated levels that achieved solid bilateral fusion (Lenke grade A) are shown. For all assessment methods, no significant differ-
ences in fusion rate between treatments were determined at all time-points.
TABLE I. Mean Range of Motion () of Treated Spine Levels in Response to Pure Moment Loading After 12 Weeks
Parameter Control ABG ABG/BCPgranules ABG/BCPputty
Lateral bending 18.8  1.9 (a) 5.3  2.2 7.7  3.9 10.7  2.1 (b)
Flexion extension 20.7  2.9 (c) 8.0  2.2 7.9  2.8 11.6  2.0 (d)
Data presented in mean  sd.
aSignificantly different from all other groups, p < 0.001.
bSignificantly different from ABG, p < 0.001.
cSignificantly different from all other groups, p < 0.001.
dSignificantly different from ABG, p < 0.05.
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40% at 9 weeks and 75–87.5% at 12 weeks were deter-
mined, with no significant differences between graft types
[Fig. 3(D)].
Histological micrographs showed the presence of resid-
ual particles, BCP granules and new bone formation with
typical bone cells (Figs. 5 and 6). After 6 weeks, the forma-
tion of new bone on and between the BCP granules and the
residual autograft particles was observed [Figs. 5(A,C) and 6
(A,B,D,E)]. New bone tissue at 6 weeks had infiltrated the
BCP pores and was characterized by early, woven bone phe-
notype and fibrous tissue. Histology at 9 and 12 weeks
showed healing progression by new bone formation and
remodeling of bone into lamellar bone in and around the
BCP material, as well as the development of bone marrow
spaces with hematopoietic cells [Figs. 5(B,D) and6(C,F)].
Osteoblasts were observed typically lining the surface of new
bone in the process of bone formation (Fig. 5) as well as osteo-
cytes residing in lacunae. Multi-nucleated cells were present on
the surface of the BCP material (Fig. 5), indicating foreign body
giant cell- and osteoclast-mediated resorption of the material.
Histomorphometric analysis
Quantitative histomorphometry results of bone tissue and
material in the fusion mass are presented in Figure 7. At all
time-points, bone percentage was between 30% and 40%
with no significant differences between groups and no
trends being apparent over the different time-points.
Regarding the percentage of BCP material, a gradual reduc-
tion in material percentage during time was apparent for
both BCPgranules and BCPputty. However, the percentage of
material for ABG/BCPputty was significantly higher than for
ABG/BCPgranules at all time-points except time-point zero.
DISCUSSION
The objective of this study was to evaluate the performance
of a novel BCP bone graft with submicron surface topogra-
phy as an autograft extender against autograft alone in a val-
idated model of PLF in rabbit. The BCP was applied either as
granules or as granules embedded in a fast-dissolving poly-
meric carrier, both in combination with an equal volume of
FIGURE 4. Histological panel overviews (H&E) of fusion masses of spines treated with (A) ABG, (B) ABG/BCPgranules, and (C) ABG/BCPputty at
12 weeks post-surgery. All these fusion masses were determined to be fused, as indicated by the continuous bone mass (dashed line) between the
adjacent transverse processes (yellow asterisks). The presence of calcium phosphate granules in the fusion mass was observed in the autograft
extender groups (black arrows).
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FIGURE 5. Histological micrographs (H&E) of the fusion masses of (A, B) ABG/BCPgranules and (C, D) ABG/BCPputty at (A, C) 6 weeks and
(B,D) 12 weeks. At 6 weeks, bone tissue was characterized by woven bone and fibrous tissue and was observed at the material surface
and inside of the pores. After 12 weeks, bone tissue had developed toward mature bone phenotype as determined by the presence of
hematopoietic bone marrow spaces. Osteoblasts were observed depositing new bone matrix (yellow asterisks) and large, multi-nucleated
cells were seen at the material surface resorbing material (black arrows). Legend: m: calcium phosphate material; b: bone; f: fibrous tis-
sue; bm: bone marrow.
FIGURE 6. Histological micrographs (Tetrachrome) of the fusion masses of (A–C) ABG/BCPgranules and (D–F) ABG/BCPputty at (A, D; frames B, E)
6 weeks, and (C, F) 12 weeks. After 6 weeks, newly formed woven bone (blue) was observed growing from autograft particles, forming a direct con-
nection between calcium phosphate granules and autograft particles. After 12 weeks, bone maturation was evident from the development of
mature bone matrix (red) between granules as well as the presence of large bone marrow spaces. Legend: a: autograft particle; m: calcium phos-
phate material; nb: new bone; bm: bone marrow; mb: matured bone.
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autologous iliac crest bone. Outcomes were determined by
an extensive range of assessment methods, including manual
palpation, X-ray, micro-CT, mechanical testing, histology, and
histomorphometry at endpoints of 6, 9, and 12 weeks post-
surgery.
Based on all endpoints, all the three groups (ABG,
ABG/BCPgranules, ABG/BCPputty) showed a gradual progres-
sion in bone formation and maturation during time, leading to
solid fusion masses between the transverse processes after
12 weeks. Results of fusion assessment by manual palpation,
radiography (X-ray, microCT) and histology revealed equiva-
lent fusion rates between all groups at all time-points, with
satisfactory fusion rates after 12 weeks corresponding to lit-
erature.23,32 Previous research has demonstrated that certain
methods of fusion assessment (e.g., micro-CT) are more sensi-
tive than other techniques (e.g., manual palpation, X-ray),23,33
although each technique has advantages and disadvantages.
Manual palpation and X-ray assessments are of a more subjec-
tive nature and allow global assessment of the fusion mass as
compared to the high level of detail offered by micro-CT and
histology. However, while histology is an excellent method to
show bone formation, it is suboptimal for the assessment of
fusion status as it may give false non-union results. A histolog-
ical slide provides a two-dimensional representation of a
more complex three-dimensional fusion mass and apparent
non-contiguity between bone islands in a two-dimensional
histological slide could still be contiguous in another plane. A
disadvantage of fusion assessment by micro-CT (and X-ray) is
that bone mineral and calcium phosphate-based graft mate-
rials have similar radiopacity, which can limit the ability to
differentiate these components in a fusion mass. Despite all
this, an advantage of preclinical investigation compared to the
clinic is that multiple descriptive methods for fusion charac-
terization can be used concurrently to develop a robust over-
all comparison between treatment outcomes. As expected, we
noted variation in fusion rate depending on the analytical
technique used, but our hypothesis that there would be no
difference between autograft and BCP treatments was corrob-
orated by each of the four analyses conducted.
In accordance with the fusion assessment results,
mechanical testing of the spines after 12 weeks showed a
substantially lower ROM (~50%) in LB and FE in all groups
as compared to non-operated controls, indicating successful
spinal fusion. There was no significant difference (p > 0.05)
in ROM in LB or FE between the BCP treatments. There was
more laxity for ABG/BCPputty compared to ABG, but this did
not correspond with a lower fusion rate using radiographical
or histological methods. Moreover, there was no difference
between groups when characterizing the volume of new
bone formation by histomorphometry. Furthermore, a recent
study in a sheep PLF model in which BCPgranules and BCPputty
were implanted as stand-alone grafts and compared to an
autograft positive control reported no difference in any
mode of flexibility analysis.34 We found no difference
between the positive control, autograft, and the negative
control, an un-operated spine, when tested in axial rotation
in this study. This could be attributed either to the low sen-
sitivity of the test method in this mode of flexibility or the
possibility that more time was required to reach a complete
fusion.
In line with the above results, histology and histomor-
phometry of the fusion mass showed the formation and mat-
uration of bone tissue in the fusion mass during time in all
groups, with typical bone morphology and bone-related cell
types. Osteoclast-like, multinucleated cell-mediated were
observed resorbing the BCP material, which are thought to
play a role in the unique bone forming ability of calcium
phosphates with submicron scale surface topography.15
Although the fusion rate evidently increased between
6 and 12 weeks post-surgery, the percentage of bone tissue
in available space in the fusion mass as determined by histo-
morphometry remained stable (30–40%) in all groups dur-
ing this period. This suggests that bone formation had
reached an equilibrium at 6 weeks and thereafter, as new
FIGURE 7. Diagrams presenting the results of histomorphometrical analysis, showing percentage of bone in available space (A) and material (B) in
the fusion mass over time (means  sd). Symbols: *significantly different from material, ABG/BCPputty, 6 weeks p < 0.01; •significantly different from
material, ABG/BCPputty, 9 weeks p < 0.001; #significantly different from material, ABG/BCPputty, 12 weeks p < 0.001.
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bone formation was in balance with ongoing bone resorption
and remodeling. Between 6 and 12 weeks, this process
resulted in consolidation and maturation of the grafts into a
stable fusion mass at 12 weeks. In retrospect, addition of an
earlier time-point at 3 weeks post-surgery would have pro-
vided insight in the progress of bone formation before the
equilibrium was reached. With regard to the calcium phos-
phate material in the fusion mass, the higher percentage of
material in the ABG/BCPputty group is likely the result of a
higher density of granules in the implant bed related to
implantation within the polymeric carrier, whereas granules
implanted without carrier might become slightly more dis-
persed. However, this does not seem to have influenced
fusion efficacy, as shown by the other assessment methods.
For the proper evaluation of autograft extender perfor-
mance in this rabbit PLF model, the amount of autograft
used in combination with the extender material is a critical
factor. Indeed, several studies have noted the positive corre-
lation between the amount of implanted autograft and the
fusion rate.27,28,35 By using a low quantity of autograft that
is unable to achieve fusion by itself (1 cc), the effect of an
autograft extender on fusion success can be reliably evalu-
ated (bone paucity model27). We have determined previ-
ously that 1 cc of autograft alone was not able to achieve
spinal fusion [unpublished data], a finding that has also been
reported by others27,28 However, almost all studies on cal-
cium phosphate autograft extenders that have claimed equiv-
alence to autograft in this model have used quantities of
autograft considerably larger than 1 cc combined with the
extender.36–39 This may lead to a significant overestimation
of the effect of these materials because the volume of auto-
graft might be sufficient to achieve fusion by itself, as was
clearly demonstrated in a study by Miller et al.28 In contrast,
by use of 1 cc of autograft combined with 1 cc of BCP in the
current study, we have unequivocally shown that this mate-
rial with submicron surface topography is an effective auto-
graft extender, since it enhanced the fusion success of 1 cc of
autograft up to the level of the positive control (2 cc of auto-
graft). These results suggest that calcium phosphates with
submicron topography are highly effective bone graft mate-
rials for use in spinal fusion procedures.
It has been demonstrated that biomaterial surface prop-
erties can alter the phenotype of macrophages,16–18 which
are key modulators in the tissue response to medical
implants. These plastic cells are known to differentiate into
various subtypes in response to environmental cues. Typi-
cally, they are classified into two main subpopulations that
have different functionality: the M1 macrophage, which is
microbicidal and promotes an inflammatory response that
can contribute to tissue injury, and the pro-healing, anti-
inflammatory, M2 macrophage, which is involved in tissue
repair and healing.40 Although having opposing functions,
the presence of both subpopulations is important for normal
wound repair and also for the integration and healing of
bone grafts.40 Studies have suggested that an upregulation in
anti-inflammatory M2 macrophages after a transient phase
of inflammation dominated by M1 macrophages is crucial
for enhanced vascularization and osteogenesis.20,21 Recently,
it has been shown that calcium phosphates with submicron
surface topography promote naïve macrophages to adopt the
M2 phenotype in vitro.22 The promotion of M2 macrophages
on submicron topographies might be the underlying mecha-
nism behind the enhanced angiogenesis and bone healing
observed with calcium phosphates with submicron topogra-
phy in vivo.11,14,22
It should be mentioned that all pre-clinical studies are
limited in the attempt to represent a model of a human sce-
nario. The rabbit PLF model provides a biological bed to
evaluate the in vivo performance of bone grafting options
that may facilitate fusion. This model is limited in the ana-
tomical and physiological differences between rabbit and
human as well as the lack of fixation by instrumentation
compared to human PLF. Although this study investigated
calcium phosphates with submicron topography, no calcium
phosphates without submicron topography were included as
control. This would have allowed a more critical evaluation
of the effect of submicron topography on bone graft perfor-
mance in this model. Also, inclusion of additional time-points
would have provided valuable information on the healing
process, like the progression of bone formation early in the
healing process (i.e., 3 weeks) and also the amount of
remaining BCP material after a longer term of implantation
(i.e., 26 weeks). A recommendation for future studies in this
model is to include calcium phosphates with submicron
topography as stand-alone grafts instead of autograft
extenders, in order to evaluate the performance of these
materials in the absence of autograft. However, recently,
these materials have already shown potential as stand-alone
grafts in an Ovine model of instrumented PLF.34
CONCLUSIONS
This study shows equivalent fusion rates between ABG and a
novel synthetic BCP with submicron surface topography
when used as a 1:1 graft extender in a single-level rabbit
PLF model. Using an extensive range of evaluation tech-
niques, a gradual progression of bone formation was deter-
mined, leading to high fusion rates after 12 weeks, with
consistency between groups. Implantation of the BCP mate-
rial within a fast-resorbing polymeric carrier did not affect
treatment outcomes, indicating that the carrier did not
inhibit the bone forming-ability of the material. By these
findings, we can conclude that this novel BCP is a promising
bone graft material for clinical spinal fusion procedures.
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